Welcome to Diagnostics and Therapeutics: a new multidisciplinary forum for diseases diagnosis and treatment

Qianshan Ding

doi:10.55976/dt.120221541

Home /

Archives /

Diagnostics and Therapeutics, Volume 1 Issue 1, 2022 /

Editorial

Welcome to Diagnostics and Therapeutics: a new multidisciplinary forum for diseases diagnosis and treatment

Qianshan Ding ¹ ^*

1. Luminescience Press, Wuhan, Hubei; Medical Research Center, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, Shaanxi

Correspondence: iamdqs@163.com

DOI: https://doi.org/10.55976/dt.120221541

Received

15 January 2022
Revised

10 February 2022
Accepted

22 February 2022
Published

25 February 2022

The history of human civilization is a history of struggles against disease. Today, for developing and underdeveloped countries, the lack of medical resources and medical technology limits the average life expectancy of residents and the quality of lives of patients. Infectious diseases including parasitic diseases are still dangerous killers for the population of these countries. While for developed countries, the incidence of cardiovascular and cerebrovascular diseases, diabetes and tumors caused by the aging of the population is increasing rapidly, which brings heavy social and economic burdens to families and countries. In recent years, COVID-19 pandemic has markedly changed our lifestyles, and millions of people have lost their family members, relatives and friends. Humans have been looking for more advanced and reliable diagnosis and treatment strategies to deal with diseases.
In 2021, I left clinical work and devoted myself to the launch of Luminescience journals. As the founder of Luminescience Press, I am delighted and honored to be the Co-editors-in-chief of Diagnostics and Therapeutics (DT), since it will enable me to participate in the odyssey of humans fighting diseases and pursue a better life in a different way. We hope to build an international and diversified editorial team and make DT a platform that can provide global surgeons, physicians and medical scientists with the latest information on diagnostics and therapeutics for life-changing and life-threatening diseases. We welcome the manuscripts that share the cutting-edge knowledge of diagnostic procedures and techniques and also papers that report the experience and perspectives of clinical practice. This journal will mainly accept case reports, clinical trials, meta-analysis and reviews on disease diagnosis and treatment, and we also look forward to original articles that explore novel technologies of diseases diagnosis and treatment.
DT, as the same as other Luminescience journals, in addition to publishing in English, our professional editing team will also provide the readers with abstracts in Chinese, and the full text of some selected manuscripts will be published in both Chinese and English. We also welcome authors to provide us with abstract in their native languages after the article is accepted. Additionally, DT is an open access (OA) and peer-reviewed journal, and all published contents in DT can be freely available to read, download and share by authors, scientific communities and readers all over the world. We advocate and practice open science by publishing OA journals, which is also beneficial for authors to enlarge global visibility and explore wider collaboration.
With our sustained efforts and the support from the editorial board members, reviewers, authors and readers, DT will surely make great progress in the next few years and become an outstanding medical journal.

Download PDF

Download XML

How to Cite

Ding, Q. “Welcome to Diagnostics and Therapeutics: A New Multidisciplinary Forum for Diseases Diagnosis and Treatment”. Diagnostics and Therapeutics, vol. 1, no. 1, Feb. 2022, p. 1, doi:10.55976/dt.120221541.

Download Citation

Issue

Diagnostics and Therapeutics, Volume 1 Issue 1, 2022

Section

Editorial

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright licenses detail the rights for publication, distribution, and use of research. Open Access articles published by Luminescience do not require transfer of copyright, as the copyright remains with the author. In opting for open access, the author(s) should agree to publish the article under the CC BY license (Creative Commons Attribution 4.0 International License). The CC BY license allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license, users are free to share (copy, distribute and transmit) and remix (adapt) the contribution, including for commercial purposes, providing they attribute the contribution in the manner specified by the author or licensor.

Home /

Archives /

Diagnostics and Therapeutics, Volume 1 Issue 1, 2022 /

Editorial

Welcome to Diagnostics and Therapeutics: a new multidisciplinary forum for diseases diagnosis and treatment

How to Cite

Issue

Section

License

Follow Luminescience

Further Information

Home / Archives / Diagnostics and Therapeutics, Volume 1 Issue 1, 2022 / Editorial

Welcome to Diagnostics and Therapeutics: a new multidisciplinary forum for diseases diagnosis and treatment

How to Cite

Issue

Section

License

Follow Luminescience

Further Information

Home /

Archives /

Diagnostics and Therapeutics, Volume 1 Issue 1, 2022 /

Editorial